This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Novavax Inc
NVAX : NASDAQ : Health Care
$4.50 -0.02 | -0.44%
Today's Range: 4.45 - 4.56
Avg. Daily Volume: 3,089,100
09/16/14 - 4:00 PM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
NVAX NOVAVAX INC 4.76 1134.85 n/m 29.27 65.41
KERX KERYX BIOPHARMACEUTICALS INC 14.34 1316.70 n/m 10.00 42.85
CBPO CHINA BIOLOGIC PRODUCTS INC 53.77 1316.34 23.08 212.09 8.91
ACOR ACORDA THERAPEUTICS INC 30.53 1274.47 66.37 355.16 11.74
PTLA PORTOLA PHARMACEUTICALS INC 28.49 1179.40 n/m 9.61 269.39
HALO HALOZYME THERAPEUTICS INC 9.40 1177.88 n/m 58.86 10.20
INSY INSYS THERAPEUTICS INC 32.42 1118.81 21.86 166.74 319.04
ARIA ARIAD PHARMACEUTICALS INC 5.97 1116.46 n/m 48.98 137.36
LGND LIGAND PHARMACEUTICAL INC 52.46 1090.17 149.89 54.31 31.68
BLUE BLUEBIRD BIO INC 36.90 1055.19 n/m 25.39 300.85
ANAC ANACOR PHARMACEUTICALS INC 24.75 1039.40 16.39 19.19 76.12
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

NVAX Ind Avg S&P 500
n/m 85.52 19.69

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs